Lykan Bioscience Welcomes Kenneth LeClair as Chief Technology Officer
Lykan Bioscience Welcomes Kenneth LeClair as Chief Technology Officer News provided by Share this article Share this article HOPKINTON, Mass., April 13, 2021 /PRNewswire/ -- Lykan Bioscience, a contract development and manufacturing services organization and provider of the first true end-to-end solution for the manufacture of cell-based therapies, welcomes Kenneth LeClair as Chief Technology Officer. Ken joins the executive leadership team and will be responsible for leading the company's Manufacturing Science and Technology and Process Development teams. Ken brings over 40 years of academi...